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The chicken ovalbumin upstream promoter-transcription factors (COUP-TFI and II) make up the most conserved
subfamily of nuclear receptors that play key roles in angiogenesis, neuronal development, organogenesis, cell fate
determination, and metabolic homeostasis. Although the biological functions of COUP-TFs have been studied
extensively, little is known of their structural features or aspects of ligand regulation. Here we report the ligand-free
1.48 A ˚ crystal structure of the human COUP-TFII ligand-binding domain. The structure reveals an autorepressed
conformation of the receptor, where helix a10 is bent into the ligand-binding pocket and the activation function-2
helix is folded into the cofactor binding site, thus preventing the recruitment of coactivators. In contrast, in multiple
cell lines, COUP-TFII exhibits constitutive transcriptional activity, which can be further potentiated by nuclear receptor
coactivators. Mutations designed to disrupt cofactor binding, dimerization, and ligand binding, substantially reduce
the COUP-TFII transcriptional activity. Importantly, retinoid acids are able to promote COUP-TFII to recruit coactivators
and activate a COUP-TF reporter construct. Although the concentration needed is higher than the physiological levels
of retinoic acids, these findings demonstrate that COUP-TFII is a ligand-regulated nuclear receptor, in which ligands
activate the receptor by releasing it from the autorepressed conformation.
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Receptor. PLoS Biol 6(9): e227. doi:10.1371/journal.pbio.0060227
Introduction
Nuclear receptors (NRs) are ligand-inducible transcription
factors that transmit physiological signals of a wide variety of
ligands, such as classical steroid hormones, retinoic acid,
thyroid hormone, and vitamin D [1,2]. The NR family also
includes a large number of orphan receptors for which
speciﬁc ligands have yet to be identiﬁed [3]. Among the most
extensively studied orphan receptors are the chicken ovalbu-
min upstream promoter-transcription factors (COUP-TFs),
which belong to the NR2F subfamily. This family includes
three human members—COUP-TFI (EAR3), COUP-TFII
(ARP-1), and the more distant EAR2—as well as the Drosophila
melanogaster protein Seven-up (Svp), xCOUP-TFIII from
Xenopus laevis, and the zebraﬁsh homolog SVP46 [4,5].
COUP-TFs are the most evolutionarily conserved NRs among
all species, and within the NR2F subfamily, the homology in
both the DNA-binding domain (DBD) and ligand-binding
domain (LBD) is extremely high. For example, the LBDs of
COUP-TFI or II are essentially identical in different species
(99.6% among vertebrates and .90% with the D. melanogaster
protein Svp), suggesting that these domains are critical for
the biological function of COUP-TFs even though a ligand
has yet to be identiﬁed [4].
In mammals, the COUP-TF orphan NRs regulate many key
biological processes, including angiogenesis, neuronal devel-
opment, organogenesis, cell fate determination, metabolic
homeostasis, and circadian rhythm [6–12]. COUP-TFII–null
mutants exhibit defects in angiogenesis and heart develop-
ment and die before embryonic day 10.5 [7]. COUP-TFII also
regulates vein identity by repressing Notch signaling [13]. In
addition, COUP-TFII heterozygous females show signiﬁcantly
reduced fertility, irregular estrus cycles, delayed puberty, and
retarded postnatal growth [14]. Conditional deletion of
COUP-TFII in the uterus results in decidualization and
embryo attachment defects, leading to infertility [15], where-
as partial ablation of COUP-TFII causes severely impaired
placental formation and contributes to miscarriage [16].
Tissue-speciﬁc knockouts of COUP-TFII in the mesenchyme
cause an alteration in the anterior-posterior and radial
patterning of the stomach and causes Bochdalek-type
congenital diaphragmatic hernia [17,18]. Altogether, the role
of COUP-TFII during angiogenesis and heart development,
female reproduction, and mesenchymal-epithelial signaling
has been well established, even though it is unclear whether
COUP-TFII is regulated by ligands.
The LBD of NRs plays a crucial role in their functions,
including ligand recognition, receptor dimerization or
oligomerization, and ligand-dependent activation. Crystallo-
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PLoS BIOLOGYgraphic studies have revealed that NR activity is primarily
determined by the conformational states of the activation
function-2 (AF2) helix located at the C terminus of the LBD
[19]. In the agonist-bound receptor, the AF2 helix is stabilized
in an active conformation to form a charge-clamp for
interaction with coactivator LXXLL motifs [20–22]. These
structures show that the LXXLL coactivator motif adopts a
two-turn a helix with the three leucine side chains ﬁtting into
a hydrophobic pocket between two charge-clamp residues
that cap both helical ends. In contrast to the coactivator-
bound structures, the longer LXXXIXXXL/I corepressor
motif adopts a three-turn a helix and forces the AF2 helix
to shift conformations to make room for the larger motif,
thereby disrupting the coactivator binding groove [23].
Alternatively, antagonists can also bind to LBDs and promote
an ‘‘autoinhibited’’ conformation. The structure of the
estrogen receptor a (ERa) in complex with the antagonist 4-
hydroxytamoxifen (OHT) shows the AF2 helix binding in the
coactivator binding site, rendering the LBD incapable of
binding to coactivators [21,24]. While a large number of
ligand-bound NR structures have been determined, few
structures of NR LBDs exist in the absence of ligands
[20,25]. The structures of apo-RXRa have been solved as
both a dimer and tetramer, and both structures show the AF2
helix extending away from the core domain of the LBD
[26,27]. In the apo-RXRa tetramer, the AF2 helix of each
monomer spans into the coactivator binding site in the
adjacent monomer of the symmetric dimer, therefore
forming an auto-repressed complex where the AF2 helix
physically blocks LBD interactions with coactivators or
corepressors [27]. These studies highlight the importance of
structural biology in revealing novel insights into NR ligand
binding and cofactor interactions. Elucidation of a COUP-TF
LBD structure is crucial for understanding how this impor-
tant subfamily of receptors is regulated.
Here we report the 1.48 A ˚ crystal structure of the LBD of
human COUP-TFII. This structure represents a novel
structure of an auto-inhibited NR, a conformation where
the intramolecular interaction between the AF2 helix and the
cofactor binding site physically blocks the interaction with
either coactivators or corepressors. We also use cell-based
activation assays to identify coactivators that enhance COUP-
TFII activation and residues that play a role in ligand binding,
cofactor recruitment, and dimerization. Furthermore, we
provide evidences that retinoid acids can promote the ability
of COUP-TFII to interact with coactivator motifs, and to
activate a COUP-TF reporter construct. These observations
establish that COUP-TFII is a ligand-regulated NR and reveal
a structural mechanism that ligand-dependent activation of
COUP-TFII is in part mediated through the release of the
receptor from the auto-repression state.
Results
Structure Determination and Crystal Structure of the
COUP-TFII LBD
The human COUP-TFII LBD was puriﬁed to homogeneity
in a ligand-free state (see Methods). Although it has been
shown that the inclusion of LXXLL motifs is crucial for the
crystallization of a number of NR LBD complexes [20,28–30],
we crystallized the COUP-TFII LBD in the absence of
cofactor peptides. Molecular replacement solutions were
obtained using the structure of the 9-cis retinoic acid–bound
RXRa LBD [29] because of its 45% sequence homology to
COUP-TFII, but these solutions failed to produce an
interpretable electron density map for the lower third of
the protein, including the bottom portion a10 and the AF2
helix. As a result, independent phase information was
determined by multiple isomorphous replacement with data
from derivative crystals containing iodine, yielding a clear
structure for majority of the missing regions of COUP-TFII.
There is one LBD molecule per asymmetric unit, but COUP-
TFII forms a symmetric dimer through crystal packing. The
data collection and reﬁnement statistics are shown in Table 1.
Figure 1A shows two views of the overall structure of the
COUP-TFII LBD monomer. The structure contains 10 a
helices that are folded into a typical three-layered helical
sandwich seen in other NRs. In the structure, two COUP-TFII
monomers packed against each other to form a dimer, with
its overall dimer conﬁguration resembling the RXR homo-
dimers or heterodimers (Figure 1B). The COUP-TFII LBD
dimer buries 975 A ˚ 2 of surface area and is formed primarily
by residues from helices a10 (cyan), a9, a8, and a7, as well as
the loop between a8 and a9. The dimer interface is made up
of residues involved in hydrophobic interactions and hydro-
gen bonding (Table 2), with the majority of the hydrophobic
interactions observed between residues found on the N-
terminal half of helix a10 of each monomer, which forms a
parallel coiled-coil structure in the crystal. Most residues in
the interface between helices a7, a9, and the loop between a8
and a9 are charged and are primarily involved hydrogen
bonding.
In the absence of ligand, helix a10 bends at V373 and
causes the C-terminal portion of a10 to collapse into the
lower half of the receptor, the region where ligands have been
found to bind in other NR LBDs [30]. While the top half of
a10 is involved in the dimer interface, the lower half folds
into the ligand-binding pocket, preventing the binding of
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COUP-TFII as a Low-Affinity Retinoic Acid Receptor
Author Summary
Unlike other classes of receptors, nuclear receptors can bind directly
to DNA and act as transcription factors, playing key roles in
embryonic development and cellular metabolism. Most nuclear
receptors are activated by signal-triggering molecules (ligands) and
can regulate their activity by recruiting coactivator proteins.
However, the ligands are unknown for a subset of ‘‘orphan’’ nuclear
receptors, including the chicken ovalbumin promoter-transcription
factors (COUP-TFI and II, and EAR2). COUP-TFs are the most
conserved nuclear receptors, with roles in angiogenesis, neuronal
development, organogenesis, and metabolic homeostasis. Here we
demonstrate that COUP-TFII is a ligand-regulated nuclear receptor
that can be activated by unphysiological micromolar concentrations
of retinoic acids. We determined the structure of the ligand-free
ligand-binding domain of the human COUP-TFII, revealing the
autorepressed conformation of the receptor, where helix a10 is bent
into the ligand-binding pocket and the activation function-2 helix is
folded into the cofactor binding site, thus preventing the recruit-
ment of coactivators. These results suggest a mechanism where
ligands activate COUP-TFII by releasing the receptor from the
autorepressed conformation. The identification of COUP-TFII as a
low-affinity retinoic acid receptor suggests ways of searching for the
endogenous ligands that may ultimately link retinoic acid and
COUP-TF signaling pathways.ligands and possibly contributing to the stability of the
ligand-free state of the protein (Figure 1A). In contrast to the
structure of RXRa bound to 9-cis retinoid acid (9cRA), where
the binding pocket is occupied by the ligand and helix a10 is
fully extended [27], the structure of COUP-TFII shows that
the ligand binding site is occupied by hydrophobic and
aromatic residues from a3 (I212, A216, L220), a5 (W249, F253,
A257), the loop following a5 (M262), a7 (F295), a10 (I378,
F382, F383), and from the AF2 helix (I392) (Figure 1C). Due to
the bulky size of these aromatic side chains and the dense
pack of the binding pocket in COUP-TFII, there is no room
for any ligand to bind in this conformation. In fact, when
calculating available cavity size in this structure, two small
cavities were identiﬁed with volumes of 18 A ˚ 3 and 12 A ˚ 3 in
size (magenta and white, respectively, Figure 1D) [31]. In
comparison, the volume of a single methyl group is
approximately 25 A ˚ 3, and based on this structure, the cavities
in COUP-TFII would be too small to accommodate a ligand of
this size.
The kink in helix a10 and the subsequent collapse of the
binding pocket of COUP-TFII allows the AF2 helix, which
follows a10, to bind in the cofactor binding site of the LBD.
The sequence IETLIRDML from COUP-TFII AF2 helix
(residues 392–400, where underlined residues are identical
or similar to leucine or isoleucine) is highly related to the
LXXLL coactivator motif or the LXXXIXXXL corepressor
motif, and its binding mode resembles that of the coactivator
SRC-1 peptide motif bound to RXRa from the RXRa/PPARc
heterodimer [29] or the corepressor silencing mediator of
retinoid and thyroid receptor (SMRT) peptide from the
PPARa-GW6471 structure [23] (Figure 1E and 1F). The AF2
helix is stabilized in the cofactor binding site by both
hydrogen bonding and hydrophobic interactions. The N-
terminal end of AF2 is stabilized by a hydrogen bond between
Q393 (AF2) and R246 (a4), and the C-terminal end of the AF2
is stabilized by hydrogen bonding between the conserved
charge clamp residue R228 (a3) and two backbone carbonyl
groups from residues M399 and L400 (AF2) (Figure 1G).
These hydrogen bonds lock the AF2 in place at the ends of
the helix, while hydrophobic interactions help stabilize AF2
in the cofactor binding groove. I392, I396, M399, and L400
extend directly into the core of COUP-TFII and make Van
der Waals contacts with residues from a3, a4, a5, and a10
(Figure 1G). In this orientation of the AF2 helix, neither
coactivators nor corepressors are able to bind to COUP-TFII,
and therefore this structure represents an autorepressed
form of this orphan NR.
COUP-TFII Acts as a Transcriptional Activator in Multiple
Cell Lines
COUP-TFII can serve as an transcriptional activator of the
NGFI-A promoter in HeLa and rat urogenital mesenchymal
cells [32] and enhance hepatocyte nuclear factor 4 (HNF4)-
induced cholesterol 7a-hydroxylase expression via a direct
repeat one site [33]. To correlate the observed structure with
COUP-TFII function, we established a cell-based assay using a
full-length COUP-TFII expression construct and a luciferase
reporter driven by the NGFI-A promoter in COS-7, HEK-
293T, and CHO-K1 cells. Results showed a dose-dependent
increase in gene expression in all three different cell types
(Figure 2A), demonstrating the ability of COUP-TFII to
activate the NGFI-A promoter in multiple cell lines.
The full-length COUP-TFII sequence consists of 414 amino
acids and can be subdivided based on primary structure into
the AF1 domain, the DBD, and the LBD (Figure 2B). To
determine the speciﬁc contribution of each domain in COUP-
TFII activation, we tested the transcriptional activity of a series
of deletion mutants in cell-based assays. Removal of the AF1
domain (residues 1–73) resulted in a decrease of COUP-TFII
activity of approximately 50% compared to wild-type levels,
althoughthepresenceoftheDBDandLBDaloneareenoughto
activate gene expression by 25-fold over empty vector control
Table 1. Data Collection and Refinement Statistics
Parameter Subparameter k1
c,d k2
c k3
c k4
c
Resolution (A ˚) 50.0–1.48 (1.53–1.48) 50.0–1.65 (1.71–1.65) 50.0–1.70 (1.76–1.70) 50.0–1.84 (1.91–1.84)
Wavelength 0.7 1.0 1.4 1.8
Completeness (%) 98.8 (91.7) 99.4 (94.8) 96.4 (74.2) 95.0 (64.5)
Rmerge
a (%) 4.7 (73.6) 5.0 (69.5) 4.7 (62.2) 4.7 (40.4)
I/r (I) 35.3 (2.1) 41.8 (2.1) 46.9 (1.9) 53.3 (3.1)
Redundancy 7.3 (5.8) 7.4 (6.2) 7.1 (5.6) 7.0 (5.4)
Total reflections 238,208 173,003 149,326 114,096
Unique reflections 32,366 23,523 21,076 16,384
Space group C2 C2 C2 C2
Cell dimensions
a (A ˚) 97.85 97.90 97.97 97.99
b (A ˚) 47.76 47.78 47.81 47.83
c (A ˚) 43.13 43.16 43.20 43.21
b (8) 100.87 100.87 100.88 100.88
Rcryst
b (%) 16.8 (18.0)
Rfree
b (%) 23.8 (30.2)
Values in parenthesis are for highest resolution shells.
a Rmerge ¼ R j I – ,I. j / RI, where I is the intensity of a given reflection.
b Rcryst¼R jFP -F Pcalc j/ RFP, where FP and FPcalc are observed and calculated structure factors. Rfree was calculated from a randomly chosen 7.7 % of reflections excluded from refinement
and Rcryst was calculated for the remaining 92.3 % of reflections.
c Data were collected from one iodine derivative crystal of COUP-TFII.
d Dataset used for refinement. Resolution used for refinement was 6.0–1.48 A ˚ (1.52–1.48 A ˚ highest resolution shell).
doi:10.1371/journal.pbio.0060227.t001
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COUP-TFII as a Low-Affinity Retinoic Acid Receptor(Figure 2C). Removal of the LBD, however, reduced more than
90% activity of COUP-TFII in our cell-based assay system and
implies that the LBD is required to bind to ligands or
coactivator proteins, or both, to activate transcription (Figure
2C). To test the activity of the LBD only, the COUP-TFII LBD
(residues 144–414)was fused to the GAL4DNA binding domain
and cotransfected with a GAL4 reporter vector in COS-7 cells.
The GAL4-COUP-TFII chimera construct activated luciferase
transcription greater than 3.5-fold over GAL4 DBD alone
(Figure 2D), indicating that the COUP-TFII LBD alone is
adequate to activate gene transcription.
COUP-TFII Activation Requires the Formation of a
Functional Dimer and the AF2 Helix
The COUP-TFII LBD forms a symmetric dimer along helix
a10 of each monomer. To determine the functional role of
the COUP-TFII dimer, we mutated two leucines (L364 and
L365) from the N-terminal portions of helix a10 to alanines.
These two leucines are key interface residues that form
critical hydrophobic interactions with I318, G361, L364,
L365, and L367 of the opposite monomer (Figure 3A and
Table 2). The L364A/L365A double mutant showed only 20%
activity in comparison to wild-type COUP-TFII, indicating
that an intact dimer interface is required for COUP-TFII to
function properly (Figure 3B). These data support the initial
studies of COUP-TF that showed the functional DNA-binding
form of COUP-TF is a dimer [34,35].
To test the role of the AF2 helix in COUP-TFII activity, we
made two truncation mutants at the C terminus. Truncation at
position S405, which removes the C-terminal nine residues but
keeps the AF2 helix intact, has little effect on the COUP-TFII
transcriptional activity. In contrast, truncation at position
Figure 1. Crystal Structure of the Ligand-Free COUP-TFII LBD
(A) Front and side views of the COUP-TFII LBD monomer with its AF2 helix colored in red.
(B) Organization of the COUP-TFII LBD dimer, showing that its dimer interface is formed predominantly by helix a10 (cyan).
(C) The packing of the ligand-binding pocket within the bottom half of the COUP-TFII LBD.
(D) Space-filling diagram shows two small cavities in COUP-TFII colored with magenta (18 A ˚3) and white (12 A ˚3).
(E and F) Overlay of the COUP-TFII LBD structure with the SRC-1 LXXLL motif (green in E) from the RXR structure or with the SMRT corepressor motif
(magenta in F) from the antagonist bound PPARa structure.
(G) Hydrogen bonds (yellow dashed lines) and hydrophobic interactions of the COUP-TFII AF2 helix (green) within the cofactor binding site.
doi:10.1371/journal.pbio.0060227.g001
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COUP-TFII as a Low-Affinity Retinoic Acid ReceptorE393, which removes the entire AF2 helix and all residues
thereafter, causes a dramatic and signiﬁcant loss of function of
the receptor (Figure 3B), indicating that an intact AF2 helix is
required for the COUP-TFII transcriptional function.
Coactivators Bind to COUP-TFII via a Charge Clamp and
Enhance Activation
Coactivator recruitment for transcriptional activation by
NRs is mediated through a conserved charge clamp pocket, in
part formed by a positively charged residue from the end of
helix a3 and a negatively charged residue from the center of
AF2 helix [19]. The charge clamp residues in COUP-TFII are
R228 from helix a3 and D398 from the AF2 helix; both point
away from the protein molecule (Figure 4A). To test the
signiﬁcance of the charge clamp in COUP-TFII activation, we
mutated these two residues and tested them in cell-based
activation assays. While single mutations of D398R and R228E
have weak effects on COUP-TFII activation, complete
removal of the charge clamp by the combined mutation
reduces activation to 40% in comparison to the wild-type
receptor (Figure 4B). These data show that an intact charge
clamp is required to interact with endogenous coactivators
for enhancing gene expression at wild-type levels.
Having shown a wild-type charge clamp capable of
interacting with coactivators is important in COUP-TFII
activity, we attempted to identify cofactor proteins that may
enhance this activation. Previous studies have shown that the
coactivators SRC-1 and GRIP1/SRC-2 can potentiate the
activity of COUP-TFI both in vivo and upstream of the NGFI-
A promoter in HeLa cells, and that PGC-1a and COUP-TFI
interact with each other on the phosphoenolpyruvate
carboxykinase (PEPCK) gene promoter [32,36,37]. Trans-
fection of the coactivators SRC-1, SRC-2, SRC-3, and PGC-
1a alone into COS-7 cells does not cause expression of
luciferase downstream of the NGFI-A promoter (Figure 4C).
However, when full-length COUP-TFII was cotransfected
with these coactivators, almost all coactivators caused a
Table 2. Interactions between COUP-TFII A and B
Nonpolar Interactions Polar Interactions
ABA B
(a8) I378 L365 (a10) (a7) E297 D324 (loop a8-a9)
(a9) C343 T358 (a10) (a7) Q298 D324 (loop a8-a9)
(a10) F360 F360 (a10) (a7) K301 D324 (loop a8-a9)
(a10) F360 G361 (a10) (a7) K301 S323 (loop a8-a9)
(a10) L364 G361 (a10) (loop a8-a9) D324 S369 (a10)
(a10) L364 L364 (a10) (a9) E335 K301 (a7)
(a10) L364 L365 (a10) (a9) E339 T358 (a10)
(a10) L365 L367 (a10) (a9) Q342 T358 (a10)
(a10) T372 R371 (a10) (a9) Q342 K362 (a10)
Residues involved in dimerization are listed along with the secondary structures. The
intermolecular interactions are grouped into polar (3.8 A ˚ cutoff) and nonpolar (4.2 A ˚
cutoff) interactions.
doi:10.1371/journal.pbio.0060227.t002
Figure 2. COUP-TFII Acts as an Activator of Transcription in Multiple Cell Lines
(A) Activation of the NGFI-A promoter reporter construct with increasing concentrations of COUP-TFII (0ng, 50ng, 100ng, 150ng, and 200 ng of the
expression vector, respectively, for each cell line).
(B) Domain structure of COUP-TFII.
(C) Effects of the COUP-TFII deletion mutants on activation of the NGFI-A promoter-driven reporter. The AF1-DBD construct activates ;2-fold above
empty vector control.
(D) Activation by the GAL4-DBD-COUP-TFII-LBD. The fold activation is the relative fly luciferase activity of the NGFI-A promoter induced by COUP-TFII
versus the control vector without COUP-TFII. All data are normalized to the activity of Renilla luciferase that was used as transfection control. For
statistical analysis, the fold induction was compared with full-length COUP-TFII or GAL4-DBD in (C) and (D), respectively.
doi:10.1371/journal.pbio.0060227.g002
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COUP-TFII as a Low-Affinity Retinoic Acid Receptorsigniﬁcant increase in the relative induction of genes
compared with COUP-TFII transactivation alone (Figure
4C). Speciﬁcally, both SRC3 and PGC-1a caused the most
signiﬁcant increase in the induction of luciferase (greater
than 2-fold), suggesting that these coactivators play a role in
COUP-TFII–mediated gene transcription, as they are found
to be co-expressed with COUP-TFII in multiple tissues
[15,38].
The coactivator SRC-3 (also called AIB1, ACTR, RAC-3,
and TRAM-1) contains three highly conserved NR box
LXXLL motifs (M1–M3) to mediate ligand-dependent inter-
actions with NRs [39–42]. After identifying that SRC-3
enhances COUP-TFII-mediated transcription by more than
2-fold, we made a series of mutations at the conserved LXXLL
motifs to LXXAA to disrupt this interaction and tested these
mutations in cell-based assays. Mutations at each of the three
motifs individually or as a combined M1–M3 mutation
reduced COUP-TFII induction below that of wild-type, full-
length receptor alone (Figure 4D). These data reveal that
COUP-TFII can interact with each of the LXXLL motifs of
SRC-3 and that disruption of any one of these motifs
signiﬁcantly reduces the SRC-3–mediated COUP-TFII tran-
scription.
An Intact Pocket Is Important for COUP-TFII Activation
The ligand-binding pocket of the apo-COUP-TFII struc-
ture is packed tightly with hydrophobic residues that leave
little space for the binding of small molecules due to the kink
of helix a10 (Figure 1). However, a sizeable cavity (;600–700
A ˚ 3) for ligand binding was created when we built an active
model of the COUP-TFII where helix a10 is straightened
(Figure 5A). A straight helix a10 has been observed for all
agonist-bound NR LBD structures, including the active
structure of RXRa, where 9-cis-retinoid acid straightens helix
a10 from its kink conformation in the apo-structure [27,29].
In addition, analysis of the existing crystal structures of
several NR/ligand complexes and structural based sequence
alignment reveals that ligand-contacting residues in NR LBDs
are highly conserved in their relative positions within the
primary sequence (boxed residues Figure 6). Inspection of the
ligand-binding pocket of the active COUP-TFII model reveals
that the residues at the above conserved positions indeed
surround the COUP-TFII ligand-binding pocket with most of
their side chains pointing toward the interior of the pocket
(Figure 5B). Based on this information, we made a series of
mutations in several residues that line the binding pocket in
the active model of the COUP-TFII LBD, and we tested these
mutations in cell-based assays.
Six sets of mutations were made to affect COUP-TFII
ligand binding. Four sets of mutations were designed to
increase the size of the ligand-binding pocket by mutating the
corresponding residues to alanine (the double mutants I212A/
C213A, W249A/S250A, F253A/V254A, and L269A/L270A),
whereas two mutations were designed to reduce the size of
the ligand-binding pocket with mutations to tryptophan
residues (A216W and S250W). All mutations showed a
signiﬁcant decrease in activity in comparison to the wild-
type receptor (Figure 5C). Two mutants showed a 30%
decrease in activity (I212A/C213A and A216W), and four
mutants reduced activity of COUP-TFII by 50% (W249A/
S250A, S250W, F253A/V254A, and L269A/L270A). The degree
of reduction in these mutants is comparable to the mutations
in the ligand-binding pocket of SF-1, which was found to bind
to phospholipids [30,43]. These results thus suggest that
COUP-TFII may also be a ligand regulated receptor, which
requires its intact binding pocket for the optimal receptor
activity.
Activation of COUP-TFII by Retinoid Acids
The transcriptional activity of COUP-TFII in multiple cell
lines versus the autorepressed conformation observed in the
apo-COUP-TFII structure suggests a putative ligand either
Figure 3. COUP-TFII Activation Is Dependent on the Formation of a Functional Dimer and the Presence of AF2
(A) Top view of the COUP-TFII dimer showing the close packing of L364 (gray) and L365 (green) from helices a10 (cyan) in the dimer interface.
(B) Effects of the L364A/L365A double mutant and the AF2 deletion mutant on COUP-TFII activation of the NGFI-A promoter. For easy comparison, the
relative fold of activation by the wild-type receptor is set to 1. The statistical analysis for the fold induction of the mutants was compared with wild type
COUP-TFII.
doi:10.1371/journal.pbio.0060227.g003
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COUP-TFII as a Low-Affinity Retinoic Acid Receptorpresent in the serum or produced in cell lines used. To test
whether there is a COUP-TFII ligand in the serum, we repeated
the activation experiment with dextran-charcoal–treated se-
rum in the hope that such treatment would strip any hydro-
phobic ligands including steroids and retinoids, thus reducing
COUP-TFII activation. Indeed, using charcoal-treated serum
greatly reduced COUP-TFII activation potential by 60%–70%
regardless the presence of the SRC-3 coactivator (Figure 7A),
suggesting the presence of a hydrophobic ligand(s) in the
serum, which is required for COUP-TFII activation.
The modeled active COUP-TFII conformation displays a
ligand-binding cavity with a size of 600–700 A ˚ 3, which can
easily adopt a steroid or retinoid ligand (Figure 5A). To
determine the identity of possible COUP-TFII ligands, we
screened a panel of steroids and retinoids for their ability to
promote COUP-TFII to recruit the SRC-3–1 LXXLL coac-
tivator motif. Both 9-cis-retinoid acid (9cRA) and all-trans-
retinoid acid (ATRA) can enhance COUP-TFII to interact
with the SRC-3–1 coactivator motif, while several steroids
show little effect (Figure 7B). Full dose curves reveal the
potency (EC50) of retinoid acids around 10–30 lM (Figure
7C). In parallel, both 9cRA and ATRA activate COUP-TFII on
the luciferase reporter driven by the NGFI-A promoter with a
similar potency of 20 lM (Figure 7D). Although the
concentrations of RAs required for activation of COUP-TFII
are 10–100 times higher than the physiological levels, these
results nevertheless establish COUP-TFII is a ligand-activated
receptor and demonstrate that both 9cRA and ATRA can
serve as low-afﬁnity ligands of COUP-TFII.
Discussion
We have solved the structure of the COUP-TFII LBD, which
reveals a novel autorepressed conformation of NRs crystallized
in the absence of ligands. In contrast, cell-based assays indicate
that COUP-TFII has a ‘‘constitutive’’ activity on the NGFI-A
promoter, which can be further potentiated by recruiting
coactivators like SRC-3 that require the LXXLL motifs. These
Figure 4. Coactivators Bind to COUP-TFII via a Charge Clamp and Enhance Activation
(A) Comparison of the RXRa charge clamp (K284 and E434 in the left) with that of COUP-TFII (right). The SRC-1 LXXLL motif is shown in green.
(B) Effects of the charge clamp mutations on COUP-TFII activation. The relative fold of activation by the wild-type receptor is set to 1 in (B), (C), and (D).
The statistical analysis for the fold induction of the mutants was compared with wild-type COUP-TFII.
(C) Effects of coactivators on COUP-TFII activation. The statistical analysis for the fold induction by coactivators was compared with the wild-type COUP-
TFII in the absence of additional coactivators.
(D) Effects of mutations in the three conserved SRC-3 LXXLL coactivator binding motifs (M1-M3) to LXXAA on the SRC-3-mediated enhancement of
COUP-TFII induction. For statistical analysis, the fold induction was compared with COUP-TFII in (B) and (C) and COUP-TFII and SRC-3 cotransfection in
(D). The statistical analysis for the fold induction by mutated coactivators was compared with that of wild type SRC-3.
doi:10.1371/journal.pbio.0060227.g004
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COUP-TFII as a Low-Affinity Retinoic Acid Receptortwo seemingly contrasting observations are reconciled by the
fact that the active COUP-TFII model contains a ligand-
binding pocket of 600–700 A ˚ 3, which can easily adopt a steroid
or retinoid ligand. In addition, both 9cRA and ATRA bind and
promoteCOUP-TFIIactivation.Theseresults demonstrate that
COUP-TFII is a ligand-regulated NR, whose full activity
requires the intact structure of the COUP-TFII coactivator
binding site, AF2 helix, dimer interface, and the residues that
make up the COUP-TFII ligand-binding pocket. Moreover, the
ability of 9cRA and ATRA to activate COUP-TFII in high
concentrations indicates that RAs are unlikely to be the
physiological ligands. Identiﬁcation of the true endogenous
ligands will require further research,which could help to reveal
the ligand-dependent signaling pathways of the COUP-TF
s u b f a m i l yo fo r p h a nN R s .
Structural Basis for the COUP-TFII Autorepressed
Conformation
The classic mechanism for activation of NRs includes that
the binding of ligands to the receptor induces the C-terminal
AF2 helix to position in the active conformation [19]. The
AF2 helix can then form a charge clamp pocket, completed by
helices a3, a3’, a4, and a5, which allows the receptor to
interact efﬁciently with coactivator proteins [19,44–46]. In
the ligand-free crystal structure of the COUP-TFII LBD, the
AF2 helix does not form the charge clamp pocket but instead
adopts an inactive conformation by occupying the coactiva-
tor binding site, thereby preventing the binding of coactiva-
tor proteins. This inactive conformation of COUP-TFII is
facilitated by the kink of helix a10, which induces the last two
turns of the C-terminal region of helix a10 to ﬁt tightly into
the ligand binding pocket. The collapse of helix a10 into the
ligand binding pocket has also been observed in the inactive
conformation of several other NRs. The CAR antagonist
androstanol induces a similar kink of helix a10 from its
straight agonist-bound conformation [47,48]. The apo-RXR
structure also has its C-terminal portion helix a10 bent into
the RXR ligand binding pocket [26,27]. It is interesting to
note that the C-terminal portion helix a10 has been proposed
as part of allosteric networks that transmit ligand binding
Figure 5. An Intact Pocket Is Important for COUP-TFII Activation
(A) An active model of COUP-TFII. This model is based on the agonist-bound RXR structure with its helix a10 (cyan) extended and AF2 (red) in the active
conformation. One cavity (magenta) with size of 659 A ˚3 is found in this conformation.
(B) The potential ligand binding pocket (magenta mesh) in the active model of the COUP-TFII LBD and its surrounding residues.
(C) Effects of pocket residue mutations on COUP-TFII activation. The relative fold of activation by the wild-type receptor is set to 1. The statistical
analysis for the fold induction of the mutants was compared with wild-type COUP-TFII.
doi:10.1371/journal.pbio.0060227.g005
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COUP-TFII as a Low-Affinity Retinoic Acid Receptorsignal across the dimer interface of NR [49,50]. Thus
structural changes of the C-terminal part of helix a10 may
represent a more general phenomenon involved in switching/
modulating the activation function of NRs.
The autorepressed conformation of COUP-TFII AF2 helix
has also been observed in two previous crystal structures of
NR LBDs. The structure of the ligand-free tetramer of RXRa
shows an autorepressed orientation where the AF2 helix
protrudes away from the core domain and spans into the
coactivator binding site in the adjacent monomer of the
symmetric dimer [27]. Although this interaction is between
two monomers, the RXRa AF2 helix physically excludes
coactivator binding in a manner similar to that found in the
structure of autorepressed COUP-TFII. The overall route
mean square deviation (RMSD) for the 116 Ca atoms that
align between the core of the LBD structures (a3, a4, a5, a7,
a8, a9, and a10 to the Val373 kink, including loops) is 1.436 A ˚ ,
which indicates a high degree of similarity between the
autorepressed structures of COUP-TFII and RXRa and
perhaps a conservation of transcriptional repression based
on their structures. The main difference between the two
structures, aside from the relative positioning of the AF2
helix, is the size of the ligand-binding pocket. As mentioned
earlier, the COUP-TFII binding pocket in its ligand-free
Figure 7. COUP-TFII Is Activated by Retinoid Acids
(A) Effects of charcoal-treated FBS on COUP-TFII activation in the presence or absence of SRC-3 coactivator. The basal activity of the NGFI-A reporter
construct in the presence of FBS and absence of COUP-TFII and SRC-3 is set as 1.
(B) Addition of 50 lM of 9cRA or ATRA to promote COUP-TFII binding to SRC-3–1 coactivator motif where the addition of steroids (50 lM) has little
effect.
(C) Concentration-response curves of 9cRA and ATRA, which show the binding affinity (EC50) of 9cRA and ATRA is 17 lM and 26 lM, respectively.
(D) Effects of ATRA and 9cRA on COUP-TFII activation of the NGFI-A promoter in COS-7 cells.
doi:10.1371/journal.pbio.0060227.g007
Figure 6. Conserved Positions of the Ligand Pocket Residues in NRs
Structure-based sequence alignment of various NR LBDs shows that ligand pocket residues (boxed by black squares) are conserved in their relative
positions within the context of their secondary structural elements (labeled underneath) of NRs. All sequences are from human proteins except Seven-
up, a COUP-TF-like orphan receptor from D. melanogaster. The Protein Databank (PDB; http://www.rcsb.org/pdb/home/home.do) codes for the ligand/
receptor complexes is: 1fmr for 9cRA-bound RXRa [28], 1lv4 for HNF4c [61], 2lbd for RARc [62], 1uhl for LXRa [63], 1pld for LXRb [64], 1ot7 for FXR [65],
1l2i for ERa [21], 1qkm for ERb [66], 2h79 for TRa[67], and 1q4x for TRb [68,69].
doi:10.1371/journal.pbio.0060227.g006
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COUP-TFII as a Low-Affinity Retinoic Acid Receptorstructure is virtually nonexistent and ﬁlled with two turns of
the C-terminal half of a10 as well as hydrophobic and
aromatic side chains. In contrast, the ligand-binding pocket
of the RXRa tetramer is I-shaped and can crystallize with an
alternative trans-isomer of retinoic acid [27]. Helix a3o f
COUP-TFII is shorter than that of RXRa and folds closer to
the center of the ligand-binding pocket, which creates a
smaller pocket in COUP-TFII. In addition, the kink in COUP-
TFII a10 occurs more N-terminally than does the separation
of a10 and a11 in RXRa (V373 versus H435, respectively),
which allows the C-terminal half of a10 to occupy deeper into
the ligand-binding pocket of COUP-TFII than RXRa.
The antagonist-bound ERa structures also share similarity
to the structure of COUP-TFII with the relative positioning of
the AF2 helix [21,24]. The binding of OHT to ERa promotes a
conformation of the AF2 helix that inhibits the binding of
coactivators or corepressors. The ERa AF2 helix mimics the
hydrophobic interactions of the coactivator peptide with a
stretch of residues that resembles a coactivator peptide
(LLEML instead of LXXLL, where the underlined residues are
identical or similar to leucine (Figure 6). Identical to the
structure of COUP-TFII, the N-terminal residue of the NR
charge-clamp in ERa (K362) interacts with the C-terminal
turn of the AF2 helix, making hydrogen bonds to the
carbonyls of M543 and L544. This interaction between AF2
and the body of the NR LBD suggests that there may be
conservation of interactions required to block the binding of
either apo-NRs or antagonist-bound NRs with coactivators or
corepressors.
The Role of Dimerization in COUP-TFII Function
The COUP-TFII crystal structure is a dimer in which two
monomers interact along the same interface, previously
identiﬁed as important in homo- and heterodimerization of
other NRs [24,26–28,46,51]. The majority of intermolecular
interactions are mediated by residues from the N-terminal
halves of helix a10, with two leucine residues forming the
hydrophobic core of the interface. The L364A/L365A double
mutant created to disrupt the dimer interface caused an 80%
reduction in COUP-TFII function (Figure 3B) and reinforces
the notion that COUP-TFs function as homodimers [34,35].
The dimeric structure and cell-based activation assays
presented here thus provide additional insight into the roles
of dimerization in COUP-TFII–mediated transcription acti-
vation. Interestingly, the residues involved in COUP-TFII
dimerization are highly homologous to those found in the
RXR dimer interface (Figure 6). It is possible that these
residues are crucial in mediating COUP-TF heterodimer
interactions with other NRs in addition to its homodimer.
COUP-TF has also been shown to serve as a repressor of
transcription by directly binding to the LBD of NRs, a process
termed transrepression [6,52,53]. This model of transrepres-
sion by COUP-TF involves the DNA-independent hetero-
dimerization of COUP-TF LBDs with other receptors, such as
TR, RAR, or RXR, and thus preventing these receptors from
activating transcription. Although the speciﬁc details of this
mechanism are unknown, one hypothesis is that once COUP-
TF heterodimerizes with other LBD, they can either suppress
the activation functions of these receptors or diminish their
ligand-binding abilities by locking them in an inactive
conformation [53]. The dimer structure of COUP-TFII solved
in a ligand-free conformation ﬁts this model of trans-
repression (Figure 1). In the absence of ligands, COUP-TFII
is able to homodimerize along a7, a9, the N-terminal portion
of helix a10, and the loop between a8 and a9 with its dimer
interface resembling RXR homodimers and heterodimer
interface [26, 27]. Conceivably, COUP-TFII would be able to
heterodimerize with the unliganded forms of NRs, such as
RXRa, through this same dimer interface and act as a
transrepressor of RXRa function by blocking the ability of
these receptors to interact with ligands and/or cofactors and
subsequently inhibiting transcription. Thus the interaction
between ligand-free, autorepressed conformation of COUP-
TFII and other members of the NR2 subfamily may be a
plausible explanation of how COUP-TFII can act as a
repressor of transcription via the above model of trans-
repression.
COUP-TFII as a Possible Retinoid Acid–Activated Receptor
Since COUP-TFI was ﬁrst cloned nearly two decades ago, it
has been puzzling whether the COUP-TF orphan NRs are
ligand-regulated [54]. Despite the absence of a known ligand
for COUP-TF, biological roles of this subfamily of NRs have
been extensively studied. The structural and biochemical
works presented in this paper have established that COUP-
TFII is a ligand-regulated receptor, whose function can be
activated by micromole concentrations of retinoic acids. This
conclusion is supported by the following evidence. The ﬁrst
and the most important observation is the contrast between
the autorepressed conformation in the apo-COUP-TFII
structure and the ability of retinoic acids to promote
COUP-TFII to interact with coactivators. The AF2 helix in
the apo-structure of COUP-TFII occupies the coactivator
binding site, thus physically blocking the receptor’s ability to
interact with coactivators. This is consistent with our
AlphaScreen results (Figure 7B), which show that COUP-TFII
is not able to interact with coactivator LXXLL motifs in the
absence of ligand. In contrast, both 9cRA and ATRA are able
to promote COUP-TFII to interact with the SRC-3 LXXLL
motifs, suggesting that these ligands are able to reshape the
AF2 conformation to accommodate the binding of coactiva-
tors. The second evidence is the ability of COUP-TFII to
activate the NGFI-A reporter in multiple cell lines, which can
be further potentiated by exogenous coactivators that require
intact LXXLL coactivator motifs. The full activity of COUP-
TFII is dependent on the intact structure of the COUP-TFII
dimer, the charge clamp pocket for coactivator binding, and
the residues that line the COUP-TFII ligand binding pocket
(Figures 2–6). These data suggest that the mode of COUP-TFII
activation is similar to the general model of NR activation, in
which ligand binding induces the AF2 helix to form a charge
clamp pocket to interact with LXXLL motifs of coactivators.
The ﬁnal evidence is that the ‘‘constitutive’’ activity of COUP-
TFII in multiple cell lines is dependent on serum used in the
assays. Charcoal-treated serum, which removes hydrophobic
ligands such as steroids or retinoids in the serum, severely
reduces COUP-TFII activation levels (Figure 7A). In contrast,
the addition of retinoid acids elevates COUP-TFII activation
(Figure 7D). Together, these data provide coherent evidences
that support the conclusion that COUP-TFII is a ligand-
regulated NR, where retinoid acids could serve as low-afﬁnity
ligands. Although retinoic acids may not be the physiologi-
cally relevant ligands for COUP-TF, because the concen-
trations of retinoic acids required for COUP-TFII activation
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acids, our results nevertheless establish that the COUP-TF
orphan receptors are ligand-regulated. Interestingly, COUP-
TFII activates the NGFI-A reporter above the no-receptor
control even with charcoal-stripped serum or in the absence
of exogenous ligands (Figure 7A and 7D), indicating there are
likely to be endogenous ligands produced in cultured cells.
Identiﬁcation of the endogenous ligands will be crucial for
understanding the ligand-dependent pathways of COUP-TF.
In addition, our data also provide a structural model of
COUP-TF activation, in which ligand activation is mediated
in part by releasing the receptor from its autorepressed
conformation. Given that both vitamin A and the COUP-TF
orphan receptors share many similar and important roles in
development, the identiﬁcation of COUP-TFII as a low-
afﬁnity retinoic acid receptor presented here provides a new
window to look into the physiological relationship between
these two previously unconnected pathways.
Materials and Methods
Protein preparation. The human COUP-TFII LBD (residues 173–
414 with C174S mutation located in the loop prior to helix a1 in the
LBD) was expressed as a 6x Histidine-GST fusion protein from the
expression vector pET24a (Novagen). BL21 (DE3) cells were grown to
an OD600 of approximately 1.0 and induced with 50 lM of isopropyl-
beta-D-thiogalactopyranoside (IPTG) at 16 8C. Six liters of cells were
harvested and resuspended in 200-ml extract buffer (10 mM Tris pH
7.3, 200 mM NaCl, and 10% glycerol) and approximately 50 lg
lysozyme, 0.1% triton X-100, 1 mM dithiothreitol (DTT), and 100 lM
PMSF were added. Cells were passed through a French Press with the
pressure set at 1,000 Pa, and lysate was centrifuged at 20,000 rpm for
30 min. The supernatant was added over a pre-equilibrated 25-ml
glutathione-sepharose 4 fast ﬂow column (Amersham Biosciences).
The column was washed with 200 ml of wash buffer (10 mM Tris pH
8.0, 1 M NaCl, 10% glycerol, and 0.1% triton X-100) followed by
buffer A (300 ml of 10 mM Tris pH 8.0, 100 mM NaCl, and 10%
glycerol). The protein was eluted using buffer A supplemented with 4
mM reduced glutathione. The 6x Histidine-GST-COUP-TFII fusion
protein was cleaved overnight with thrombin (0.5 NIH units/mg
fusion protein) at 4 8C. The cleaved COUP-TFII protein was loaded
onto a pre-equilibrated 10 ml Ni
2þ chelating sepharose column
(Amersham Biosciences) and eluted at ;8% buffer B (500 mM
imidazole in 10 mM Tris pH 8.0, 1 M NaCl, 10% glycerol).
Ethylenediamine tetraacetic acid (EDTA) and DTT were added to 1
mM and protein was concentrated for crystallization. A typical yield
of the puriﬁed COUP-TFII LBD was about 2 mg/l of cells.
Crystallization and data collection. Crystals of the COUP-TFII LBD
were grown at 20 8C in hanging drops containing 3.0 ll of the above
protein solution and 1 ll of well buffer containing 1.3 M or 1.5 M
imidazole pH 5.6 and 1% Pluronic F68 detergent (Hampton). Small
crystals (50 lm) appeared within 1 wk and grew to approximately
100–300 lm in size over the course of 3 wk. COUP-TFII crystals were
crosslinked using glutaraldehyde and soaked in increasing concen-
trations of glycerol in the above well buffer. Iodine derivatives were
soaked in the mother liquor solution supplemented with 250 mM
NH4I, 25 mM Tris, and 35% glycerol. All crystals were ﬂash frozen in
liquid nitrogen before data collection.
The COUP-TFII crystals formed in the C2 space group with a ¼
97.85 A ˚ , b¼47.76 A ˚ , c¼43.13 A ˚ , a¼c¼908, and b¼100.878 (Table 1).
The iodine datasets were collected with a MAR225 CCD detector at
the at the ID line of sector-5 at the Advanced Photon Source at
Argonne National Laboratory (Argonne, Illinois, United States). The
observed reﬂections were reduced, merged, and scaled with DENZO
and SCALEPACK in the HKL2000 package [55].
Structure determination and reﬁnement. SHARP [56] was used to
calculate initial phase information, and autoBUSTER [57] was used to
auto-build an initial model of the COUP-TFII LBD. Quanta (Accelrys)
was used to manually build the protein model followed by iterative
reﬁnement cycles with CNS [58] and REFMAC [58]. REFMAC was
used for ﬁnal reﬁnement of the COUP-TFII structure, which include
all residues except for 13 residues between a1 and a3, 17 residues
between a5 and a6, and the C-terminal seven residues. The pocket
volumes were calculated with the program voidoo using program
default parameters and a probe with a radius of 1.2 A ˚ [30] and surface
areas were calculated with areaimol from the CCP4 suite of programs
[59]. All ﬁgures were prepared using PyMOL [60].
Transient transfection assays. The expression plasmids of the
mouse COUP-TFII, PGC1-a and SRC1–3, and the NGFI-A ( 168/þ33)
promoter luciferase reporter in pXP2 were previously described [31].
All mutant COUP-TFII and SRC-3 plasmids were created by using the
QuickChange Kit (Stratagene). For the GAL4-COUP-TFII chimera
experiments, the COUP-TFII LBD construct (144–414) was cloned
into the pBind vector and cotransfected with the pG5-Luc reporter
(Promega). COS-7 and HEK-293T cells were maintained in DMEM
containing 10% fetal bovine serum (FBS) and CHO-K1 cells were
maintained in a-MEM containing 10% FBS. Cells were transiently
transfected in DMEM or a-MEM supplemented with 5% FBS and 1
mM nonessential amino acids by using Lipofectamine 2000 (Invi-
trogen) according to the manufacturer’s protocol. 24-well plates were
inoculated with 75,000 cells 24 h prior to transfection. Each well of
cells was transfected in Opti-MEM with 200 ng of reporter plasmid
and 5 ng of Renilla luciferase expression plasmid phRL-CMV
(Promega) in all experiments. COS-7 cells were used for all experi-
ments except in Figure 2A. For coactivator experiments, cells were
transfected with 100 ng COUP-TFII expression vector and 200 ng of
either wild-type or mutant coactivators. For wild-type and mutant
COUP-TFII transfections, 200 ng of DNA was used in each experi-
ment. 24–30 h after transfection, cells were harvested and ﬁreﬂy and
Renilla luciferase activities were measured.
For ligand activation assay, 50,000 COS-7 cells were plated in a 24-
well plate 24 h before transfection. Cells were transiently transfected
with 50 ng COUP-TFII expression vector, 150 ng of reporter plasmid
and 0.5 ng of phRL-CMV (Promega). Medium was changed and
compounds (all-trans retinoic acid and 9-cis retinoic acid) were
added 14 h after transfection. Cells were incubated for another 24 h
and harvested for luciferase assay by using Dual-Luciferase Reporter
Assay System (Promega). Fireﬂy luciferase values were normalized to
Renilla luciferase, which was used as an internal transfection control.
All assays were performed in triplicate. For statistical analysis, the
fold induction was compared to wild type COUP-TFII (except when
noted) using a Student’s t-test (*p , 0.05, **p , 0.01, and ***p ,
0.001).
Ligand binding assays. Ligand binding to COUP-TFII was
determined by the ability of the ligands to promote COUP-TFII to
recruit coactivator peptides, which was measured by an AlphaScreen
kit (Perkin Elmer) as described for other NRs [30]. COUP-TFII LBD
protein was puriﬁed as a 6X His-GST fusion protein for the assays.
The experiments were conducted with approximately 0.4 lM
receptor LBD and 0.1 lM of biotinylated SRC3–1 peptide (AENQRG-
PLESKGHKKLLQLLTSS) in the presence of 20 lg/ml donor and
acceptor beads in a buffer containing 50 mM MOPS, 50 mM NaF, 50
mM CHAPS, and 0.1 mg/ml bovine serum albumin, all adjusted to a
pH of 7.4. To screen for a potential ligand, 9-cis-retinoic acid (Sigma
Aldrich), all-trans-retinoic acid (BioMol), dexamethasone (Sigma
Aldrich), cortisol (Sigma Aldrich), and progesterone (Sigma Aldrich)
were added to a concentration of 50 lM. EC50 values for 9cRA and
ATRA were determined from a nonlinear least-square ﬁt of the data
based on an average of three repeated experiments, with standard
errors typically less than 10% of the measurements.
Acknowledgments
We thank J. S. Brunzelle, Zhongmin Jin, Z. Wawrzak, and W. D.
Tolbert for assistance in data collection at the Advance Photon
Source (APS).
Author contributions. MJT and HEX conceived and designed the
experiments. SWK, KSP, XEZ, JEK, RR, CV, YX, LW, and HEX
performed the experiments. SWK, KSP, XEZ, JEK, RR, CV, YX, SYT,
MJT, and HEX analyzed the data. SWK, KSW, LW, SYT, and MJT
contributed reagents/materials/analysis tools. SWK, SYT, MJT, and
HEX wrote the paper.
Funding. This work was supported in part by the Jay and Betty Van
Andel Foundation (HEX), National Institutes of Health Grants
DK71662, DK66202, and HL89301 to HEX, DK45641 and HD17379
to MJT, and HL076448 and P01-DK59820 (project 1) to SYT. Use of
the LS-CAT at APS was supported by the Ofﬁce of Science of the U. S.
Department of Energy and the Michigan Economic Development
Corporation and the Michigan Technology Tri-Corridor (Grant
085P1000817).
Competing interests. The authors have declared that no competing
interests exist.
PLoS Biology | www.plosbiology.org September 2008 | Volume 6 | Issue 9 | e227 2013
COUP-TFII as a Low-Affinity Retinoic Acid ReceptorReferences
1. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many
actors in search of a plot. Cell 83: 851–857.
2. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan
receptors. Cell 83: 841–850.
3. Kliewer SA, Lehmann JM, Willson TM (1999) Orphan nuclear receptors:
shifting endocrinology into reverse. Science 284: 757–760.
4. Tsai SY, Tsai MJ (1997) Chick ovalbumin upstream promoter-transcription
factors (COUP-TFs): coming of age. Endocr Rev 18: 229–240.
5. Germain P, Staels B, Dacquet C, Spedding M, Laudet V (2006) Overview of
nomenclature of nuclear receptors. Pharmacol Rev 58: 685–704.
6. Park JI, Tsai SY, Tsai MJ (2003) Molecular mechanism of chicken ovalbumin
upstream promoter-transcription factor (COUP-TF) actions. Keio J Med
52: 174–181.
7. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY (1999) The orphan nuclear
receptor COUP-TFII is required for angiogenesis and heart development.
Genes Dev 13: 1037–1049.
8. Qiu Y, Pereira FA, DeMayo FJ, Lydon JP, Tsai SY, et al. (1997) Null mutation
of mCOUP-TFI results in defects in morphogenesis of the glossopharyngeal
ganglion, axonal projection, and arborization. Genes Dev 11: 1925–1937.
9. Warnecke M, Oster H, Revelli JP, Alvarez-Bolado G, Eichele G (2005)
Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deﬁcient
mice impairs the functionality of the forebrain clock and affects
nociception. Genes Dev 19: 614–625.
10. Zhou C, Qiu Y, Pereira FA, Crair MC, Tsai SY, et al. (1999) The nuclear
orphan receptor COUP-TFI is required for differentiation of subplate
neurons and guidance of thalamocortical axons. Neuron 24: 847–859.
11. Zhou C, Tsai SY, Tsai M (2000) From apoptosis to angiogenesis: new
insights into the roles of nuclear orphan receptors, chicken ovalbumin
upstream promoter-transcription factors, during development. Biochim
Biophys Acta 1470: M63–68.
12. Zhou C, Tsai SY, Tsai MJ (2001) COUP-TFI: an intrinsic factor for early
regionalization of the neocortex. Genes Dev 15: 2054–2059.
13. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, et al. (2005) Suppression of
Notch signalling by the COUP-TFII transcription factor regulates vein
identity. Nature 435: 98–104.
14. Takamoto N, Kurihara I, Lee K, Demayo FJ, Tsai MJ, et al. (2005)
Haploinsufﬁciency of chicken ovalbumin upstream promoter transcription
factor II in female reproduction. Mol Endocrinol 19: 2299–2308.
15. Kurihara I, Lee DK, Petit FG, Jeong J, Lee K, et al. (2007) COUP-TFII
mediates progesterone regulation of uterine implantation by controlling
ER activity. PLoS Genet 3: e102.
16. Petit FG, Jamin SP, Kurihara I, Behringer RR, DeMayo FJ, et al. (2007)
Deletion of the orphan nuclear receptor COUP-TFII in uterus leads to
placental deﬁciency. Proc Natl Acad Sci U S A 104: 6293–6298.
17. Takamoto N, You LR, Moses K, Chiang C, Zimmer WE, et al. (2005) COUP-
TFII is essential for radial and anteroposterior patterning of the stomach.
Development 132: 2179–2189.
18. You LR, Takamoto N, Yu CT, Tanaka T, Kodama T, et al. (2005) Mouse
lacking COUP-TFII as an animal model of Bochdalek-type congenital
diaphragmatic hernia. Proc Natl Acad Sci U S A 102: 16351–16356.
19. Li Y, Lambert MH, Xu HE (2003) Activation of nuclear receptors: a
perspective from structural genomics. Structure 11: 741–746.
20. Li Y, Choi M, Suino K, Kovach A, Daugherty J, et al. (2005) Structural and
biochemical basis for selective repression of the orphan nuclear receptor
liver receptor homolog 1 by small heterodimer partner. Proc Natl Acad Sci
U S A 102: 9505–9510.
21. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, et al. (1998) The
structural basis of estrogen receptor/coactivator recognition and the
antagonism of this interaction by tamoxifen. Cell 95: 927–937.
22. Li Y, Suino K, Daugherty J, Xu HE (2005) Structural and biochemical
mechanisms for the speciﬁcity of hormone binding and coactivator
assembly by mineralocorticoid receptor. Mol Cell 19: 367–380.
23. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, et al. (2002)
Structural basis for antagonist-mediated recruitment of nuclear co-
repressors by PPARalpha. Nature 415: 813–817.
24. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, et al. (1997)
Molecular basis of agonism and antagonism in the oestrogen receptor.
Nature 389: 753–758.
25. Sablin EP, Krylova IN, Fletterick RJ, Ingraham HA (2003) Structural basis
for ligand-independent activation of the orphan nuclear receptor LRH-1.
Mol Cell 11: 1575–1585.
26. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995) Crystal
structure of the ligand-binding domain of the human nuclear receptor
RXR-alpha. Nature 375: 377–382.
27. Gampe RT Jr., Montana VG, Lambert MH, Wisely GB, Milburn MV, et al.
(2000) Structural basis for autorepression of retinoid X receptor by
tetramer formation and the AF-2 helix. Genes Dev 14: 2229–2241.
28. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, et al. (2002)
Crystal structure of the glucocorticoid receptor ligand binding domain
reveals a novel mode of receptor dimerization and coactivator recognition.
Cell 110: 93–105.
29. Gampe RT Jr., Montana VG, Lambert MH, Miller AB, Bledsoe RK, et al.
(2000) Asymmetry in the PPARgamma/RXRalpha crystal structure reveals
the molecular basis of heterodimerization among nuclear receptors. Mol
Cell 5: 545–555.
30. Li Y, Choi M, Cavey G, Daugherty J, Suino K, et al. (2005) Crystallographic
identiﬁcation and functional characterization of phospholipids as ligands
for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17: 491–
502.
31. Kleywegt GJ, Jones TA (1994) Detection, delineation, measurement and
display of cavities in macromolecular structures. Acta Crystallogr D Biol
Crystallogr 50: 178–185.
32. Pipaon C, Tsai SY, Tsai MJ (1999) COUP-TF upregulates NGFI-A gene
expression through an Sp1 binding site. Mol Cell Biol 19: 2734–2745.
33. Stroup D, Chiang JY (2000) HNF4 and COUP-TFII interact to modulate
transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). J Lipid
Res 41: 1–11.
34. Cooney AJ, Tsai SY, O’Malley BW, Tsai MJ (1992) Chicken ovalbumin
upstream promoter transcription factor (COUP-TF) dimers bind to
different GGTCA response elements, allowing COUP-TF to repress
hormonal induction of the vitamin D3, thyroid hormone, and retinoic
acid receptors. Mol Cell Biol 12: 4153–4163.
35. Sagami I, Tsai SY, Wang H, Tsai MJ, O’Malley BW (1986) Identiﬁcation of
two factors required for transcription of the ovalbumin gene. Mol Cell Biol
6: 4259–4267.
36. Herzog B, Hall RK, Wang XL, Waltner-Law M, Granner DK (2004)
Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as
a transcription ampliﬁer, is not essential for basal and hormone-induced
phosphoenolpyruvate carboxykinase gene expression. Mol Endocrinol 18:
807–819.
37. Sugiyama T, Wang JC, Scott DK, Granner DK (2000) Transcription
activation by the orphan nuclear receptor, chicken ovalbumin upstream
promoter-transcription factor I (COUP-TFI). Deﬁnition of the domain
involved in the glucocorticoid response of the phosphoenolpyruvate
carboxykinase gene. J Biol Chem 275: 3446–3454.
38. Louet JF, Coste A, Amazit L, Tannour-Louet M, Wu RC, et al. (2006)
Oncogenic steroid receptor coactivator-3 is a key regulator of the white
adipogenic program. Proc Natl Acad Sci U S A 103: 17868–17873.
39. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, et al. (1997) Nuclear
receptor coactivator ACTR is a novel histone acetyltransferase and forms a
multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569–580.
40. Li H, Gomes PJ, Chen JD (1997) RAC3, a steroid/nuclear receptor-
associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad
Sci U S A 94: 8479–8484.
41. Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW (1997) TRAM-1,
A novel 160-kDa thyroid hormone receptor activator molecule, exhibits
distinct properties from steroid receptor coactivator-1. J Biol Chem 272:
27629–27634.
42. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, et al. (1997)
AIB1, a steroid receptor coactivator ampliﬁed in breast and ovarian cancer.
Science 277: 965–968.
43. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, et al. (2005) Structural
analyses reveal phosphatidyl inositols as ligands for the NR5 orphan
receptors SF-1 and LRH-1. Cell 120: 343–355.
44. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, et al.
(1998) Structure and speciﬁcity of nuclear receptor-coactivator interac-
tions. Genes Dev 12: 3343–3356.
45. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, et al. (1998)
Hormone-dependent coactivator binding to a hydrophobic cleft on
nuclear receptors. Science 280: 1747–1749.
46. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, et al. (1998) Ligand
binding and co-activator assembly of the peroxisome proliferator-activated
receptor-gamma. Nature 395: 137–143.
47. Suino K, Peng L, Reynolds R, Li Y, Cha JY, et al. (2004) The nuclear
xenobiotic receptor CAR: structural determinants of constitutive activa-
tion and heterodimerization. Mol Cell 16: 893–905.
48. Shan L, Vincent J, Brunzelle JS, Dussault I, Lin M, et al. (2004) Structure of
the murine constitutive androstane receptor complexed to androstenol: a
molecular basis for inverse agonism. Mol Cell 16: 907–917.
49. Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, et al. (2004) Allosteric
control of ligand selectivity between estrogen receptors alpha and beta:
implications for other nuclear receptors. Mol Cell 13: 317–327.
50. Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R (2004) Structural
determinants of allosteric ligand activation in RXR heterodimers. Cell 116:
417–429.
51. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, et al. (2000)
Crystal structure of a heterodimeric complex of RAR and RXR ligand-
binding domains. Mol Cell 5: 289–298.
52. Achatz G, Holzl B, Speckmayer R, Hauser C, Sandhofer F, et al. (1997)
Functional domains of the human orphan receptor ARP-1/COUP-TFII
involved in active repression and transrepression. Mol Cell Biol 17: 4914–
4932.
53. Leng X, Cooney AJ, Tsai SY, Tsai MJ (1996) Molecular mechanisms of
COUP-TF-mediated transcriptional repression: evidence for transrepres-
sion and active repression. Mol Cell Biol 16: 2332–2340.
54. Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ, et al. (1989) COUP
transcription factor is a member of the steroid receptor superfamily.
Nature 340: 163–166.
PLoS Biology | www.plosbiology.org September 2008 | Volume 6 | Issue 9 | e227 2014
COUP-TFII as a Low-Affinity Retinoic Acid Receptor55. Otwinowski Z, Minor W (1997) Processing of x-ray diffraction data
collected in oscillation mode. Methods Enzymol 276: 307–326.
56. Bricogne G, Vonrhein C, Flensburg C, Schiltz M, Paciorek W (2003)
Generation, representation and ﬂow of phase information in structure
determination: recent developments in and around SHARP 2.0. Acta
Crystallogr D Biol Crystallogr 59: 2023–2030.
57. Roversi P, Blanc E, Vonrhein C, Evans G, Bricogne G (2000) Modelling prior
distributions of atoms for macromolecular reﬁnement and completion.
Acta Crystallogr D Biol Crystallogr 56: 1316–1323.
58. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998)
Crystallography & NMR system: A new software suite for macromolecular
structure determination. Acta Crystallogr D Biol Crystallogr 54: 905–921.
59. Collaborative Computational Project N (1994) The CCP4 suite: programs
for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–
763.
60. DeLano WL (2002) The PyMOL Molecular Graphics System. Palo Alto, CA,
USA: DeLano Scientiﬁc.
61. Wisely GB, Miller AB, Davis RG, Thornquest AD Jr., Johnson R, et al. (2002)
Hepatocyte nuclear factor 4 is a transcription factor that constitutively
binds fatty acids. Structure 10: 1225–1234.
62. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, et al. (1995) Crystal
structure of the RAR-gamma ligand-binding domain bound to all-trans
retinoic acid. Nature 378: 681–689.
63. Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, et al. (2003)
Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta
ligand-binding domains in a fully agonistic conformation. Embo J 22: 4625–
4633.
64. Williams S, Bledsoe RK, Collins JL, Boggs S, Lambert MH, et al. (2003) X-ray
crystal structure of the liver X receptor beta ligand binding domain:
regulation by a histidine-tryptophan switch. J Biol Chem 278: 27138–27143.
65. Mi LZ, Devarakonda S, Harp JM, Han Q, Pellicciari R, et al. (2003)
Structural basis for bile acid binding and activation of the nuclear receptor
FXR. Mol Cell 11: 1093–1100.
66. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, et al. (1999)
Structure of the ligand-binding domain of oestrogen receptor beta in the
presence of a partial agonist and a full antagonist. Embo J 18: 4608–4618.
67. Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, et al. (2006)
Structural rearrangements in the thyroid hormone receptor hinge domain
and their putative role in the receptor function. J Mol Biol 360: 586–598.
68. Borngraeber S, Budny MJ, Chiellini G, Cunha-Lima ST, Togashi M, et al.
(2003) Ligand selectivity by seeking hydrophobicity in thyroid hormone
receptor. Proc Natl Acad Sci U S A 100: 15358–15363.
69. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, et al. (1995) A
structural role for hormone in the thyroid hormone receptor. Nature 378:
690–697.
PLoS Biology | www.plosbiology.org September 2008 | Volume 6 | Issue 9 | e227 2015
COUP-TFII as a Low-Affinity Retinoic Acid Receptor